Skip to content
10-K

Annual Report

LEXARIA BIOSCIENCE CORP. LEXX

0001640334-25-002225

← back to feed
Filed
Nov 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Nov 25, 2025 22.23M sh
Shares Diluted FY 2025 · Aug 31, 2025 18M sh
Shares Diluted FY 2025 · Aug 31, 2024 12.38M sh
Capex FY 2025 · Aug 31, 2025 $24.65K
Capex FY 2025 · Aug 31, 2024 $43.01K
Operating Cash Flow FY 2025 · Aug 31, 2025 −$10.45M
Operating Cash Flow FY 2025 · Aug 31, 2024 −$4.96M
Stockholders Equity FY 2025 · Aug 31, 2025 $2.99M
Stockholders Equity FY 2025 · Aug 31, 2024 $8.04M
Current Liabilities FY 2025 · Aug 31, 2025 $1.49M
Current Liabilities FY 2025 · Aug 31, 2024 $1.1M
Total Liabilities FY 2025 · Aug 31, 2025 $1.57M
Total Liabilities FY 2025 · Aug 31, 2024 $1.21M
Current Assets FY 2025 · Aug 31, 2025 $3.47M
Current Assets FY 2025 · Aug 31, 2024 $7.9M
Total Assets FY 2025 · Aug 31, 2025 $4.18M
Total Assets FY 2025 · Aug 31, 2024 $8.87M
Eps Diluted FY 2025 · Aug 31, 2025 −$0.66
Eps Diluted FY 2025 · Aug 31, 2024 −$0.47
Sga Expense FY 2025 · Aug 31, 2025 $4.35M
Sga Expense FY 2025 · Aug 31, 2024 $3.85M
Rd Expense FY 2025 · Aug 31, 2025 $8.24M
Rd Expense FY 2025 · Aug 31, 2024 $2.36M
Net Income FY 2025 · Aug 31, 2025 −$11.9M
Net Income FY 2025 · Aug 31, 2024 −$5.8M
Operating Income FY 2025 · Aug 31, 2025 −$11.88M
Operating Income FY 2025 · Aug 31, 2024 −$5.75M
Gross Profit FY 2025 · Aug 31, 2025 $703.2K
Gross Profit FY 2025 · Aug 31, 2024 $459.46K